 column (45 u frit) with attached lid and collection tube, for desalting, aff purification or IP (1/pk)) Microspin (~1 ml size) column (45 u frit) with attached lid and collection tube, for desalting, aff purification or IP (1/pk) |
|||
| COLM-M2 | Alpha Diagnostics | 100 PK | EUR 152 |
 Antigen-Antibody Pen For Mouse Primary antibodies |
|||
| PEN-M2 | Alpha Diagnostics | 1 | EUR 202 |
 Pen m2 |
|||
| LF-P0523 | Abfrontier | 0.1 mg | EUR 350 |
|
Description: Pen m2 protein |
|||
Pen m2 |
|||
| LF-P0523A | Abfrontier | 0.5 mg | EUR 1247 |
|
Description: Pen m2 protein |
|||
Pen m2 |
|||
| LF-P0523B | Abfrontier | 1 mg | EUR 1998 |
|
Description: Pen m2 protein |
|||
 Gomisin M2 |
|||
| TBZ2637 | ChemNorm | 5mg | Ask for price |
 Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
| 201-12-1660 | SunredBio | 96 tests | EUR 440 |
|
|||
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
| CSB-E04774h-24T | Cusabio | 1 plate of 24 wells | EUR 165 |
|
|||
|
Description: Quantitativesandwich ELISA kit for measuring Human Pancreatic carcinoma markers-CA242 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
| 1-CSB-E04774h | Cusabio |
|
|
|
|||
|
Description: Quantitativesandwich ELISA kit for measuring Human Pancreatic carcinoma markers-CA242 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
| GA-E1676HM-48T | GenAsia Biotech | 48T | EUR 289 |
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
| GA-E1676HM-96T | GenAsia Biotech | 96T | EUR 466 |
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
| QY-E00484 | Qayee Biotechnology | 96T | EUR 361 |
, Clone: M2) Monoclonal STK16 Antibody (clone M2), Clone: M2 |
|||
| AMM08020G | Leading Biology | 0.05mg | EUR 528 |
|
Description: A Monoclonal antibody against Human STK16 (clone M2). The antibodies are raised in Mouse and are from clone M2. This antibody is applicable in WB and IHC-P, E, RNAi |
|||
, Clone: M2) Monoclonal SDSL Antibody (clone M2), Clone: M2 |
|||
| AMR09854G | Leading Biology | 0.05mg | EUR 528 |
|
Description: A Monoclonal antibody against Human SDSL (clone M2). The antibodies are raised in Mouse and are from clone M2. This antibody is applicable in WB and IHC-P, E |
|||
 ELISA Kit) Human Pancreatic Carcinoma Markers-CA242 (CA242) ELISA Kit |
|||
| abx253426-96tests | Abbexa | 96 tests | EUR 754 |
|
|||
) MART-1; Clones M2-7C10 & M2-9E3 (Concentrate) |
|||
| A00133-C | ScyTek Laboratories | 1 ml | EUR 484 |
 CLIA Kit) Rat Pyruvate Kinase,M2 (M2-PK) CLIA Kit |
|||
| abx197635-96tests | Abbexa | 96 tests | EUR 825 |
|
|||
 Cyclin M2 antibody |
|||
| 70R-51015 | Fitzgerald | 100 ul | EUR 244 |
|
Description: Purified Polyclonal Cyclin M2 antibody |
|||
Cyclin M2 antibody |
|||
| 70R-6396 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal Cyclin M2 antibody raised against the middle region of CNNM2 |
|||
 Cyclin M2 Antibody |
|||
| 20-abx008123 | Abbexa |
|
|
|
|||
) anti-HSP90beta (M2) |
|||
| LF-MA20420 | Abfrontier | 100 ug | EUR 354 |
|
Description: Mouse monoclonal to HSP90beta |
|||
 Aflatoxin M2 Standard |
|||
| SD006 | Unibiotest | 0.5ug/mL | EUR 607 |
) Anti-STK16 (M2) |
|||
| YF-MA11086 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to STK16 |
|||
) Anti-PRKRIP1 (M2) |
|||
| YF-MA11658 | Abfrontier | 50 ug | EUR 363 |
|
Description: Mouse monoclonal to PRKRIP1 |
|||
) Anti-SDSL (M2) |
|||
| YF-MA11724 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to SDSL |
|||
) Anti-SLC25A20 (M2) |
|||
| YF-MA12237 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to SLC25A20 |
|||
) Anti-G1P3 (M2) |
|||
| YF-MA13161 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to G1P3 |
|||
) Anti-GCSH (M2) |
|||
| YF-MA13215 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to GCSH |
|||
) Anti-HLF (M2) |
|||
| YF-MA13475 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to HLF |
|||
) Anti-PBP (M2) |
|||
| YF-MA14575 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to PBP |
|||
) Anti-Legumain (M2) |
|||
| YF-MA14969 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to Legumain |
|||
) Anti-BANF1 (M2) |
|||
| YF-MA16535 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to BANF1 |
|||
) Anti-PIH1D1 (M2) |
|||
| YF-MA18719 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to PIH1D1 |
|||
Anti-PRKRIP1 (M2) |
|||
| YF-MA19348 | Abfrontier | 200 ul | EUR 363 |
|
Description: Mouse monoclonal to PRKRIP1 |
|||
) Anti-AHCY (M2) |
|||
| YF-MA20271 | Abfrontier | 200 ul | EUR 363 |
|
Description: Mouse monoclonal to AHCY |
|||
) CLIA kit for Rat M2-PK (Pyruvate Kinase,M2) |
|||
| E-CL-R0582 | Elabscience Biotech | 1 plate of 96 wells | EUR 584 |
|
|||
|
Description: A sandwich CLIA kit for quantitative measurement of Rat M2-PK (Pyruvate Kinase,M2) in samples from Serum, Plasma, Cell supernatant |
|||
 Antibody) Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNUB0701-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), Concentration: 0.2mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNUB0701-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), Concentration: 0.2mg/mL |
|||
 Antibody) MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNUB0705-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Concentration: 0.2mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNUB0705-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Concentration: 0.2mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNUM0701-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), 1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNUM0705-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), 1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC040701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC040701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF405S conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC040705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF405S conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC040705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC550701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC550701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF555 conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC550705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF555 conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC550705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC610701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC610701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF660R conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC610705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF660R conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC610705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC470701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC470701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF647 conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC470705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF647 conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC470705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC050701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC050701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF405M conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC050705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF405M conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC050705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC400701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC400701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF640R conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC400705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF640R conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC400705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC430701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC430701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF543 conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC430705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF543 conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC430705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC800701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC800701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF680 conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC800705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF680 conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC800705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNCP0701-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), PerCP conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNCP0705-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNCR0701-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), RPE conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNCR0705-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), RPE conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNCA0701-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), APC conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNCA0705-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), APC conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNCAP0701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNCAP0701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNCAP0705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNCAP0705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNCB0701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNCB0701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), Biotin conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNCB0705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Biotin conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNCB0705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNCH0701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNCH0701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNCH0705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNCH0705-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC940701-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311) Antibody |
|||
| BNC940701-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Melanoma Marker(HMB45 + M2-7C10 + M2-9E3 + T311), CF594 conjugate, Concentration: 0.1mg/mL |
|||
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
|||
| BNC940705-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF594 conjugate, Concentration: 0.1mg/mL |
|||